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Abstract
Background: Mortality after coronary artery bypass grafting (CABG) is generally associated with underlying disease
and surgical factors overlooked in preoperative prognostic models. Sequential Organ Failure Assessment (SOFA) and
Acute Physiology and Chronic Health Evaluation (APACHE II) scores are widely used in intensive care units for
outcome prediction. This study investigated the accuracy of these models in predicting mortality.
Methods: Between January 2010 and April 2013, 483 patients who underwent isolated CABG were enrolled. The
clinical characteristics, outcomes, and prognostic model scores of the patients were collected. Discrimination was
assessed using the area under the curve approach.
Results: Both SOFA and APACHE II scores were effective for predicting in-hospital mortality. Among the organ
systems examined in the SOFA, the cardiac and renal systems were the strongest predictors of CABG mortality.
Multivariate analysis identified only the SOFA score as being an independent risk factor for mortality.
Conclusion: In summary, the SOFA score can be used to accurately identify mortality after isolated CABG.
Keywords: Coronary artery by pass grafting, Sequential organ failure assessment, Society of thoracic surgeons
mortality risk, Mortality, Cardiorenal syndrome
Background
Studies have reported that the mortality of cardiac surgery
ranges from 2.94 to 32.5 according to different surgeries
and population [1–3]. Prognostic models developed by the
Society of Thoracic Surgeons European System for Cardiac
Operative Risk Evaluation for mortality and morbidity are
widely used before operations. However, unexpected intra-
operative factors might influence the outcomes of these
patients. General severity scoring systems, such as the
Acute Physiology and Chronic Health Evaluation (APACHE
II) [4] and Sequential Organ Failure Assessment (SOFA)
[5], are generally used in intensive care units (ICUs) to
predict mortality, but their validity in isolated coronary
artery bypass grafting (CABG) patients is not well estab-
lished [6], Therefore, we undertook a post hoc analysis of a
prospectively accumulated database to evaluate the accur-
acy of the SOFA and APACHE II for predicting postopera-
tive mortality on the date of surgical ICU admission.
Methods
Study participants and data collection
This clinical study was conducted in full compliance with
the ethical principles of the Declaration of Helsinki and
was consistent with Good Clinical Practice guidelines and
the applicable local regulatory requirements. The local
institutional review board of Chang Gung Memorial
Hospital approved our study protocol. The requirement
for obtaining patient consent was waived because the
study utilized prospectively collected data for post hoc
analysis. This database was constructed for medical quality
assurance. Patients of ages older than 20 years were en-
rolled in this study. Between January 2010 and April 2013,
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483 consecutive patients who received isolated CABG in a
single tertiary referral hospital were investigated. Pertinent
data on patients’ medical history including clinical charac-
teristics, demographic data, and a scoring system were ex-
tracted from this database. Congestive heart failure (CHF,
based on Framingham criteria and defined using New
York Heart Association classifications), shock (defined as
hypotension with systolic arterial blood pressure of
90 mmHg despite adequate fluid resuscitation), and myo-
cardial infarction (MI; defined according to the 2007
Expert Consensus Document of Circulation from the
European Heart Journal) were evaluated. Illness severity
was assessed using APACHE II and SOFA [4, 5] scores
determined on the day of ICU admission. The primary
outcome was in-hospital mortality. Patients who under-
went CABG received standard medical care according to
the 2011 American College of Cardiology Foundation/
American Heart Association guidelines for CABG [7].
Statistical analysis
The Kolmogorov–Smirnov test was used to determine
the normal distribution for each variable. Student’s t test
was used to compare the means of continuous variables
and normally distributed data; otherwise, the Mann–
Whitney U test was used. Categorical data were tested
using the chi-square test or Fisher exact test. Further-
more, the Hosmer–Lemeshow goodness-of-fit test was
used for calibration when evaluating the number of ob-
served and predicted deaths for the entire range of death
probabilities. Discrimination was assessed using the area
under the curve (AUC), which was compared using a
nonparametric approach [8]. Cumulative survival curves
as a function of time were generated using the Kaplan–
Meier approach and compared using a log-rank test. All




The 483 patients were all adults and had a mean age of
62.9 years; of them, 17.6% (n = 85) were female. Overall
in-hospital mortality was 9.9%. All patient characteristics
are listed in Table 1. Compared with the survival group,
the mortality group was older, was more likely to have
end-stage renal disease (ESRD), and was more likely to
be on ventilator support before surgery. Those who died
also had higher creatinine (Cr), lower albumin (ALB),
and lower hemoglobin (Hb) levels and poorer preopera-
tive heart conditions such as greater more preoperative
intra-aortic balloon pumping (IABP) usage, extracorpor-
eal membrane oxygenation (ECMO) usage, more shock,
more recent MI, and a lower ejection fraction. Table 2
lists the surgical details and postoperative data of the
patients. The nonsurvivors required the surgery more
urgently and had more intraoperative IABP and ECMO
usage compared with the survivors. They also had a
greater proportion of shock as well as higher Cr, and
lower Hb levels after the operation. ICU stay was mark-
edly prolonged in the mortality group.
Scoring systems and in-hospital mortality
The mean Society of Thoracic Surgeons (STS) mortality
risk, European System for Cardiac Operative Risk
Evaluation (EuroSCORE) II, SOFA, and APACHE II scores
were 7.7, 6.8, 6.6, and 12.9, respectively. All scores differed
significantly between the survivors and nonsurvivors. The
AUC results listed in Table 3 indicate that the SOFA, STS
mortality risk, APACHE II, and EuroSCORE II all had
satisfactory discriminatory ability (0.912 ± 0.019, P < .001,
0.898 ± 0.017, P < .001, 0.866 ± 0.027, P < .001, and 0.863 ±
0.022, P < .001). Both the SOFA and STS mortality risk
Table 1 Preoperative demographic data and clinical characteristics









Age (years) 62.9 ± 0.5 62.3 ± 0.5 68.8 ± 1.5 <0.001
Sex, female (%) 85 (17.6) 75 (17.2) 10 (20.8) 0.535
Diabetes mellitus (%) 252 (52.2) 223 (51.3) 29 (60.4) 0.228
Hypertension (%) 376 (77.8) 340 (78.2) 36 (75.0) 0.617
ESRD (%) 57 (11.8) 43 (9.9) 14 (29.2) <0.001
Shock (%) 66 (13.7) 42 (9.7) 24 (50.0) <0.001
Mechanical ventilation,
n (%)
45 (9.3) 33 (7.6) 12 (25.0) <0.001
Serum Creatinine
(mg/dL)
2.0 ± 0.12 1.79 ± 0.11 3.85 ± 0.51 <0.001
Albumin (g/L) 3.85 ± 0.03 3.89 ± 0.30 3.25 ± 0.93 <0.001
Hemoglobin (g/dL) 12.5 ± 0.1 12.7 ± 0.1 10.8 ± 0.3 <0.001
hs-CRP (mg/L) 26.4 ± 2.7 23.1 ± 2.7 58.6 ± 16.3 <0.001
Preoperative heart condition
CHF Fc III/IV (%) 77 (15.9) 63 (14.5) 14 (29.2) 0.008
IABP, (%) 60 (12.4) 40 (9.2) 20 (41.7) <0.001
ECMO, (%) 11 (2.3) 7 (1.6) 4 (8.3) 0.017
Ejection fraction (%) 53 ± 1 54 ± 1 40 ± 2 <0.001
Recent MI, (%) 225 (46.6) 191 (43.9) 34 (70.8) 0.001
CAD vessels 2.80 ± 0.02 2.8 ± 0.02 2.8 ± 0.07 0.437
Preoperative scores
STS-risk of mortality 7.7 ± 0.6 5.4 ± 0.5 27.9 ± 3.1 <0.001
EuroSCORE II 6.8 ± 0.4 5.4 ± 0.4 18.9 ± 2.1 <0.001
Abbreviations: CAD coronary artery disease, CHF Fc congestive heart failure
functional class, ECMO Extracorporeal Membrane Oxygenation, ESRS End stage
renal disease, EuroSCORE European System for Cardiac Operative Risk
Evaluation, hs-CRP high-sensitivity C-reactive protein, IABP intra-aortic balloon
pump, ICU intensive care unit, MI myocardial infarction, NS not significant, STS
Society of Thoracic Surgeons
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were significantly superior to EuroSCORE II (P = .016 and
P < .001, respectively). Low P values for the Hosmer–Leme-
show test indicated that there were no statistical hints
against an assumed fit of the scoring system. Both the post-
operative SOFA and APACHE II scores exhibited close
agreement between the observed and expected mortality.
Figure 1 presents the observed and predicted mortality
results for the scoring systems stratified into quintiles.
To investigate the individual organ systems that affect
post-CABG mortality, we dissected the SOFA score
components to calculate the discriminatory power of
each (Table 4). The cardiovascular system followed by
the renal system had the higher discriminatory power,
after which were coagulation and neurology, both with
similar discriminatory power. Liver and respiration had
the lowest discriminatory power among the individual
factors. Combining the cardiovascular and renal system
components resulted in increased discriminatory power,
but this power was still less than that of the entire SOFA
score (P < .001).
Figure 2 illustrates the cumulative survival rate, strati-
fied according to SOFA score tertiles. Patients in the
high and middle tertiles had significantly lower survival
rates than did those in the low tertile (log-rank P < .001)
Logistic regression analysis for mortality according to
postoperative variables
According to univariable and multivariable logistic re-
gression models based on patient characteristics and
postoperative factors, only the age, postoperative ECMO
and SOFA score were independently associated with
mortality (Table 5).
Discussion
This present investigation examined 483 isolated CABG pa-
tients admitted to an ICU after operation. The overall in-
hospital mortality rate was 9.9%, which was higher than
that reported in previous studies. Tamayo et al. studied
post-cardiac surgery patients and found a 90-day in-
hospital mortality rate of 8.8% [9]. Curiel-Balsera et al. per-
formed a study using the ARIAM Andalus adult cardiac
surgery registry, which included data from 11 hospitals in
the autonomous region of Andalusia between 2008 and
2011, and reported intra-ICU mortality of 7.7% and 30-day
mortality of 9.3% [10]. Rodríguez-Rieiro et al. reported an
observed mortality rate of 7.69% [11]. Our preoperative
STS and EuroSCORE II scores were much higher than
those reported in the literature [12–14]. Potential explana-
tions for this are as follows. First, the current data were
collected in the largest tertiary referral hospital in Northern
Taiwan, in which a large proportion of patients have
advanced comorbidities such as ESRD (11.8%), which is
well known to be a high-risk population for surgical mortal-
ity [15]. Second, in traditional Chinese culture, families
typically seek treatment for patients even when doing so
involves high surgical risk and a high likelihood of
Table 2 Postoperative outcomes and clinical characteristics of









Urgent operation (%) 124 (25.7) 91 (20.9) 33 (68.8) <0.001
On pump (%) 332 (68.7) 293 (67.4) 39 (81.3) 0.049
On pump-clamp
time (minutes)
- 89.7 ± 3.4 77.8 ± 11.4 -
On pump-bypass
time (minutes)
- 115.8 ± 2.7 135.5 ± 11.1 -
Bypass graft number 2.98 ± 0.04 2.91 ± 0.04 2.69 ± 0.09 0.076
Postoperative data
IABP, (%) 111 (23.0) 95 (21.8) 16 (33.3) 0.072
ECMO, (%) 26 (5.4) 11 (2.5) 15 (31.3) <0.001
Shock 143 (29.7) 105 (24.2) 38 (79.2) <0.001
Bilirubin Total (units/L) 1.18 ± 0.04 1.16 ± 0.04 1.29 ± 0.14 0.195
Serum Creatinine
(mg/dL)
1.82 ± 0.1 1.68 ± 0.10 3.32 ± 0.41 <0.001
Hemoglobin (g/dL) 10.6 ± 0.1 10.7 ± 0.1 9.5 ± 0.3 <0.001
Postoperative scores
SOFA 6.6 ± 0.1 6.2 ± 0.1 10.8 ± 0.4 <0.001
APACHE II 12.9 ± 0.3 12.0 ± 0.2 21.1 ± 0.9 <0.001
Patient outcome
ICU stay (day) 4.9 ± 0.4 4.4 ± 0.4 10.3 ± 1.6 <0.001
Abbreviations: ECMO Extracorporeal Membrane Oxygenation, IABP intra-aortic
balloon pump, SOFA Sequential Organ Failure Assessment
Table 3 Calibration and discrimination results for the scoring methods in predicting mortality
Calibration Discrimination
goodness-of-fit (χ2) df p AUC ± SE 95% CI p
Postoperative SOFA 3.361 6 0.762 0.912 ± 0.019 0.875 – 0.949 <0.001
Postoperative APACHE II 6.335 8 0.610 0.866 ± 0.027 0.813 – 0.919 <0.001
STS-risk of mortality 29.654 8 <0.001 0.898 ± 0.017 0.864 – 0.932 <0.001
EuroSCORE II 40.472 8 <0.001 0.863 ± 0.022 0.821 – 0.906 <0.001
Abbreviations: APACHE Acute Physiology and Chronic Health Evaluation, AUC area under the curve, CI confidence interval, df degree of freedom, EuroSCORE
European System for Cardiac Operative Risk Evaluation, SE standard error, SOFA Sequential Organ Failure Assessment, STS Society of Thoracic Surgeons
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complications [16]. Third, of the patients who underwent
emergent and salvage CABG, some had severe preoperative
cardiogenic shock (12.4%) and received mechanical circula-
tory support (MCS), namely patients with IABP (13.2%)
and ECMO (2.5%), both of which are positively associated
with CABG mortality. Early mortality in patients undergo-
ing emergent and salvage CABG is substantial, with the
in-hospital mortality rates of 13 and 41%, respectively [17].
Patients requiring preoperative MCS have operative mortal-
ity of 37.2%, and those undergoing CABG as a salvage pro-
cedure have an operative mortality of 53.3% [18]. Finally,
the low total hospital costs (approximately 10% of the costs
in the United States) and large reimbursement amounts
under the health insurance system of Taiwan may have
affected the quality of patient care and negatively affected
the CABG outcomes [19].
Numerous prognostic risk models for cardiac surgery have
been introduced into current practice. Among them, the
EuroSCORE, published in 1999 [20]; revised EuroSCORE II,
published in 2012 [21]; and STS score, published in 2008
[22] are widely used. These assessments, which are based on
collected data, can be used to predict the risk of cardiac
surgery mortality according to patient demographics and
clinical variables, and can be determined using an easy-to-
use online calculator. No previous study has compared pre-
operative and postoperative risk modes for predicting the
occurrence of mortality in isolated CABG. Our data showed
that preoperative scores underestimated mortality in high-
risk patients (Fig. 1). Thus, a postoperative score is necessary
for ICU doctors to reevaluate condition severity. In this
study, we demonstrated that SOFA and APACHE II scores
at ICU day 1 have similar predictive effectiveness for
Fig. 1 Observed and expected (mean) mortality rates divided by quintiles of expected mortality calculated using the STS risk model, EuroSCORE
II, SOFA, and APACHE II
Table 4 Calibration and discrimination results for each sofa parameter in predicting mortality
Calibration Discrimination
goodness-of-fit (χ2) df p AUC ± SE 95% CI p
Respiration 6.006 1 0.014 0.529 ± 0.046 0.439 – 0.619 0.524
Renal 16.566 2 <0.001 0.803 ± 0.033 0.738 – 0.867 <0.001
Liver 0.421 1 0.516 0.578 ± 0.048 0.484 – 0.673 0.087
Cardiovascular 2.947 3 0.400 0.805 ± 0.034 0.737 – 0.872 <0.001
Coagulation 2.929 1 0.087 0.677 ± 0.047 0.584 – 0.770 <0.001
Neurological 5.550 1 0.018 0.703 ± 0.048 0.608 – 0.797 <0.001
Cardiovascular + Renal 2.303 4 0.680 0.871 ± 0.023 0.825 – 0.917 <0.001
Abbreviations: AUC area under the curve, CI confidence interval, df degree of freedom, SE standard error
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mortality. SOFA score based upon respiratory, renal, hep-
atic, cardiovascular, neurological and coagulation systems,
were used as an assessment tool to evaluate outcome. The
Cardiac Surgery Score (CASUS) was designed for predicting
cardiac surgery mortality by using 10 variables measured
upon ICU admission [23]. Several studies have concluded
that the scale can effectively predict cardiac surgery mortal-
ity, and have recommended its use [24]. The CASUS also
evaluates several organ functions and has similar parameters
to those of SOFA. However, lactic acid was not routinely
recorded postoperatively in our ICU; thus, we could not
validate CASUS results in this study. The Post Cardiac
Surgery (POCAS) prognostic score was developed on the
basis of 4 parameters (mean arterial pressure [MAP], lactate,
bicarbonate, and international normalized ratio [INR]), and
has favorable discrimination in predicting postcardiac mor-
tality [9]. Although we did not compare POCAS and SOFA
scores, MAP and lactate represent the cardiac system, bicar-
bonate represents the renal system, and the INR represents
coagulation and the liver system, which might explain why
the SOFA and POCAS results were similar.
Patients receiving CABG mainly exhibit 2 complex cardi-
orenal syndromes. First, patients with coronary arterial dis-
ease are usually older and have DM, HTN, and CHF, which
cause chronic kidney disease (CKD) through microvascular
and macrovascular pathophysiology. Moreover, sympathetic
tone, renin–angiotensin–aldosterone system activation, and
endothelin release cause excess vasoconstriction and impair
glomerular filtration. CKD also induces erythropoietin defi-
ciency, decreased vitamin D receptor activation, and fluid
acumination, which might affect cardiac function through
cardiomyopathy. Second, during CABG, patients experi-
ence low cardiac output, nonpulsatile blood flow,
hemolysis, and free iron release, which induce oxidative
stress and reactive oxygen species and impair kidney func-
tion. Otherwise, excess diuretic and analgesic use might re-
sult in acute kidney injury (AKI). In fact, AKI affects 12–
30% of patients undergoing CABG, contributes to increased
in-hospital mortality and reduced long-term survival, and
results in high medical expenditure, CKD, and dialysis de-
pendence [25–28]. Postoperative AKI not only contributes
to increased in-hospital mortality and reduced long-term
survival but also results in high medical expenditure, CKD,
and dialysis dependence. In the present study, the mortality
group patients exhibited anemia, hypoalbuminemia, and
poor renal function, which reflect the severity of heart fail-
ure, water retention, inflammation, and malnutrition and
which are known risk factors for mortality after cardiac sur-
gery [14, 29, 30]. The occurrence of cardiac and renal dys-
function varies among patients admitted to the ICU with
CABG, with different degrees of association existing be-
tween individual organ system failure and ICU mortality
[31]. This explains why combining the cardiac and renal
factors of the SOFA score is an accurate technique for
assessing mortality in patients who receive CABG.
Study limitations
Despite the favorable results obtained in this study, some
crucial limitations must be noted. First, our study was
limited by its post hoc analysis nature and relatively
Fig. 2 Kaplan–Meier survival curves of mortality with log-rank test
results according to SOFA score tertiles










Age 0.052 0.016 1.053 (1.022–1.086) 0.001
Diabetes
mellitus
0.300 0.312 1.350 (0.732–2.489) 0.336
Hypertension 0.294 0.357 0.342 (0.667–2.699) 0.409
ESRD 1.207 0.356 3.342 (1.662–6.719) 0.001
Serum
Creatinine
0.211 0.054 1.235 (1.111–1.372) <0.001
Hemoglobin −0.412 0.100 0.662 (0.545–0.805) <0.001
IABP 0.576 0.330 1.779 (0.923–3.394) 0.081
ECMO 2.962 0.459 13.343 (7.876–47.560) <0.001
SOFA 0.737 0.151 2.090 (1.556–2.807) <0.001
Multivariate logistic regression
Age 0.062 0.021 1.064 (1.020–1.110) 0.004
ECMO 2.298 0.678 9.959 (2.636–37.620) 0.001
SOFA 0.711 0.097 2.036 (1.685–2.460) <0.001
constant −12.623 1.851 - -
Abbreviations: ECMO Extracorporeal Membrane Oxygenation, IABP intra-aortic
balloon pump, SOFA Sequential Organ Failure Assessment
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small number of cases from a single referral center in
Asia; care should be used when generalizing the results
to different populations. Second, scoring was performed
only on the first day of ICU admission. The sequential
application of these scoring systems (for example, daily
or weekly) may reflect dynamic aspects of clinical
diseases and thus provide more complete data on mor-
tality risk. Finally, the etiology of mortality is often
multifactorial, and postoperative care factors that were
not included in the scoring systems may have affected
the prediction results.
Conclusions
The analysis results highlight the strong discriminative
power of the SOFA and APACHE II scores in predicting
mortality in patients after CABG. Among the different
components of the SOFA, renal dysfunction is the only
one that is also incriminated in cardiac failure, indicating
that mortality is often part of a cardiorenal syndrome.
The multivariate analysis identified the SOFA score
alone as an independent risk factor for mortality. Higher
SOFA scores are correlated with higher mortality. In
conclusion, SOFA might be the most effective tool for
guiding the use of preventive and early therapeutic strat-
egies to prevent mortality and improve clinical outcomes
for patients who undergo CABG. Future studies could
conduct multicenter and repeated measurements to en-
hance accuracy for future clinical management.
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